🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
17,57 USD
Máx. histórico
178,74
2144 días
Split 1:6 del 12/07/2012
Caída desde máximo
-90,17%
Rango 52 semanas
14,68 – 24,68
Variación hoy
-7,48%
Cierre anterior
18,99
Rango de hoy
17,44 – 18,92
Volumen hoy
1.859.162
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,43%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 21 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/03/2019 | 126,95 | 127,13 | 124,70 | 126,47 | -0,28% | 1,91% | 968.400 |
| 18/03/2019 | 128,12 | 130,11 | 125,30 | 126,82 | -1,20% | 3,75% | 1.206.500 |
| 15/03/2019 | 129,48 | 130,96 | 127,02 | 128,36 | -0,81% | 3,04% | 1.158.900 |
| 14/03/2019 | 132,60 | 133,62 | 129,30 | 129,41 | -2,41% | 3,26% | 1.209.200 |
| 13/03/2019 | 134,93 | 135,52 | 131,53 | 132,60 | -1,06% | 2,96% | 756.100 |
| 12/03/2019 | 134,38 | 135,83 | 132,72 | 134,02 | -0,28% | 2,31% | 822.900 |
| 11/03/2019 | 130,63 | 135,20 | 130,00 | 134,39 | +2,74% | 3,98% | 1.233.900 |
| 08/03/2019 | 130,88 | 132,24 | 128,50 | 130,80 | -2,34% | 2,86% | 1.354.600 |
| 07/03/2019 | 134,01 | 136,35 | 129,57 | 133,93 | +1,27% | 5,06% | 2.179.200 |
| 06/03/2019 | 142,50 | 142,50 | 131,55 | 132,25 | -11,12% | 7,68% | 6.683.600 |
| 05/03/2019 | 145,59 | 150,90 | 144,15 | 148,79 | +2,28% | 4,64% | 1.528.100 |
| 04/03/2019 | 148,44 | 148,44 | 143,10 | 145,48 | -0,82% | 3,60% | 1.457.700 |
| 01/03/2019 | 144,97 | 148,34 | 144,46 | 146,69 | +1,70% | 2,68% | 1.259.700 |
| 28/02/2019 | 148,92 | 148,92 | 143,00 | 144,24 | -4,91% | 3,98% | 2.344.400 |
| 27/02/2019 | 151,99 | 155,23 | 145,25 | 151,68 | +8,31% | 6,57% | 4.382.900 |
| 26/02/2019 | 143,00 | 143,24 | 138,15 | 140,04 | -2,50% | 3,56% | 988.600 |
| 25/02/2019 | 143,93 | 149,70 | 142,38 | 143,63 | +2,61% | 5,09% | 2.011.200 |
| 22/02/2019 | 137,50 | 140,31 | 135,49 | 139,98 | +2,52% | 3,51% | 776.600 |
| 21/02/2019 | 143,58 | 145,46 | 134,29 | 136,54 | -2,87% | 7,78% | 965.200 |
| 20/02/2019 | 140,65 | 142,38 | 137,52 | 140,57 | +0,22% | 3,46% | 697.100 |
| 19/02/2019 | 137,60 | 140,73 | 137,60 | 140,26 | +1,31% | 2,27% | 609.000 |
| 15/02/2019 | 134,90 | 139,24 | 134,00 | 138,45 | +2,65% | 3,88% | 877.700 |
| 14/02/2019 | 135,00 | 135,95 | 132,53 | 134,88 | +0,10% | 2,53% | 664.600 |
| 13/02/2019 | 133,59 | 135,72 | 131,13 | 134,74 | +1,38% | 3,44% | 998.400 |
| 12/02/2019 | 127,90 | 133,26 | 127,90 | 132,91 | +4,65% | 4,19% | 880.800 |
| 11/02/2019 | 130,00 | 132,79 | 126,95 | 127,00 | -0,68% | 4,49% | 1.247.300 |
| 08/02/2019 | 135,92 | 136,47 | 126,14 | 127,87 | -6,96% | 7,60% | 2.149.700 |
| 07/02/2019 | 144,30 | 147,55 | 134,13 | 137,44 | -2,86% | 9,30% | 2.353.600 |
| 06/02/2019 | 141,84 | 142,31 | 139,06 | 141,49 | -0,16% | 2,29% | 1.093.200 |
| 05/02/2019 | 141,85 | 144,99 | 141,09 | 141,71 | +0,08% | 2,75% | 1.148.100 |